Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Rare Disease Foundation, Vancouver, Canada | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Metabolic diseases and mitochondrial disorders are caused by genetic mutation which lead to disruptions in energy producing pathways in our body. Enough energy or calories must be given in the diet to ensure normal growth and development. Currently, energy needs for patients with metabolic and mitochondrial diseases are not measured, but is estimated using a mathematical equation based on healthy children. This may lead to under feeding or overfeeding of calories, and has negative nutritional implications.
The clinical standard for measuring energy needs is the use of indirect calorimeter.The indirect calorimeter takes individualized measurements for each patient and therefore will enable dietitians and clinicians to provide sufficient calories in the diet to better manage the disease and promote normal growth and development.
We believe daily energy requirements will vary within metabolic diseases (Phenylketonuria) and mitochondrial disorders (mitochondrial fatty acid oxidation defect, POLG1 mutation etc.).
The objective of this preliminary study is to measure resting energy expenditure in children living with metabolic and mitochondrial conditions and data obtained will be used to generate future hypothesis and will form a basis for future studies.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Metabolic Disease- Phenylketonuria | |||
| Mitochondrial disorder |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Resting Energy Expenditure | Resting Energy Expenditure will be measured by carbon dioxide production and oxygen consumption. | 1 hour |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Children (1-18y) diagnosed with either phenylketonuria or a mitochondrial disorder
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Rajavel Elango, PhD | Child & Family Research Institute/University of British Columbia | Principal Investigator |
| Sylvia Stockler-Ipsiroglu | University of British Columbia/Faculty of Pediatrics | Study Chair |
| Ramona Meni Salvarinova Zivkovic | University of Bristish Columbia/Faculty of Pediatrics | Study Chair |
| Howard Parsons | University of British Columbia/Faculty of Pediatrics | Study Chair |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Child & Family Research Institute | Vancouver | British Columbia | V5Z4H4 | Canada |
Not provided
| ID | Term |
|---|---|
| D028361 | Mitochondrial Diseases |
| D010661 | Phenylketonurias |
| ID | Term |
|---|---|
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
| D020739 | Brain Diseases, Metabolic, Inborn |
| D001928 | Brain Diseases, Metabolic |
Not provided
Not provided
Not provided
Not provided
Not provided
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
| D009422 | Nervous System Diseases |
| D000592 | Amino Acid Metabolism, Inborn Errors |
| D008661 | Metabolism, Inborn Errors |
| D030342 | Genetic Diseases, Inborn |
| D009358 | Congenital, Hereditary, and Neonatal Diseases and Abnormalities |